Evaluation of Serum Bladder Cancer Specific Nuclear Matrix Proteins - 1 levels in Non-Muscle Invasive Bladder Cancer Patients.

Biochemical study of E-Cadherin and SATB1 in Urothelial Bladder Carcinoma of Egyptian Patients

VALUE OF BIOCHEMICAL URINARY MARKERS IN DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER PATIENTS

Evaluation of macrophage migration inhibitory factor in bladder cancer

Tumour-associated macrophages (IL-23+CD14+ subset) levels during bladder cancer progression

Telomerase Reverse Transcriptase and miR-34a in diagnosis of non-muscle invasive bladder cancer

Clinical importance of P53 and P21 determination as a biomarkers in bladder cancer and bilharzial patients

Evaluation of IGF-2 Gene Expression in Urine and its Potential Use as Biomarker for Bladder Cancer

Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC)

Evaluation of pyruvate kinase M2 (PKM2) and epidermal growth factor receptor (EGFR) expression and their clinicopathologic significance in bladder urothelial carcinoma